Page last updated: 2024-08-21

diepoxybutane and Myelodysplastic Syndromes

diepoxybutane has been researched along with Myelodysplastic Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, K; Korgaonkar, S; Vundinti, BR1
Guc-Scekic, M; Joksic, G; Joksic, I; Leskovac, A; Petrovic, S; Slijepcevic, P; Vujic, D1

Other Studies

2 other study(ies) available for diepoxybutane and Myelodysplastic Syndromes

ArticleYear
Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
    Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:1

    Topics: Adolescent; Carcinoma, Squamous Cell; Cells, Cultured; Child; Child, Preschool; Chromosome Breakage; Chromosome Fragility; Chromosomes, Human; Consanguinity; Epoxy Compounds; Fanconi Anemia; Female; Humans; India; Infant; Leukemia, Myeloid; Male; Mitomycin; Myelodysplastic Syndromes; Young Adult

2010
Fanconi anemia is characterized by delayed repair kinetics of DNA double-strand breaks.
    The Tohoku journal of experimental medicine, 2010, Volume: 221, Issue:1

    Topics: Adolescent; Apoptosis; Cells, Cultured; Child; Child, Preschool; Cross-Linking Reagents; Diagnosis, Differential; DNA Breaks, Double-Stranded; DNA Repair; Epoxy Compounds; Fanconi Anemia; Female; Fibroblasts; Fluorescent Antibody Technique, Indirect; Histones; Humans; Kinetics; Male; Myelodysplastic Syndromes; Predictive Value of Tests

2010